SAGE THERAPEUTICS
SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.
SAGE THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sagerx.com
Total Employee:
501+
Status:
Active
Contact:
6172998379
Email Addresses:
[email protected]
Total Funding:
2.7 B USD
Technology used in webpage:
LetsEncrypt Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Organization Schema IPv6 Yoast WordPress SEO Plugin Google Maps JsDelivr Yoast SEO Premium
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Soterix Medical
Soterix Medical develops devices and accessories based on neuromodulation and brain stimulation technologies.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Biogen Idec
Biogen Idec investment in Post-IPO Equity - SAGE Therapeutics
Foresite Capital
Foresite Capital investment in Series C - SAGE Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series C - SAGE Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - SAGE Therapeutics
OrbiMed
OrbiMed investment in Series C - SAGE Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series C - SAGE Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series B - SAGE Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - SAGE Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series A - SAGE Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-09-21 | Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer |
Official Site Inspections
http://www.sagerx.com Semrush global rank: 1.68 M Semrush visits lastest month: 14.6 K
- Host name: aea60fdf1a932c684.awsglobalaccelerator.com
- IP address: 76.223.51.166
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108